ArticleJournal of managed care & specialty pharmacy2021

Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States.

Karin Butler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.